Drug Resistance Mutations (DRMs) for Long-Acting Injectable Cabotegravir and Rilpivirine (CAB/RPV LAI) in the HIV-1 Subtype A6 Epidemic in PolandMICROORGANISMSIF4.22025-02-010OAAI
The Clinical Course and Outcomes of Patients Hospitalized Due to COVID-19 during Three Pandemic Waves in Poland: A Single Center Observational StudyJOURNAL OF CLINICAL MEDICINEIF2.92022-12-136OAAI
Evaluation of Clinical Biomarkers Related to CD4 Recovery in HIV-Infected Patients-5-Year ObservationVIRUSES-BASELIF3.52022-10-181OAAI
IMMUNE-ESCAPE MUTATIONS AND STOP-CODONS IN HBSAG CIRCULATES IN A RELEVANT PROPORTION OF PATIENTS WITH CHRONIC HBV INFECTION EXPOSED TO ANTI-HBV DRUGS IN EUROPE: IMPLICATIONS FOR HBV TRANSMISSION IN THE SETTING OF VACCINATION AND DISEASE PROGRESSIONJOURNAL OF HEPATOLOGYIF332016-01-010PREAI
Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE)JOURNAL OF INFECTIOUS DISEASESIF4.52015-07-0124OAAI
Evolving Patterns of HIV-1 Transmitted Drug Resistance in Poland in the Years 2000-2008JOURNAL OF MEDICAL VIROLOGYIF4.62010-05-2514PREAI